Evidence map›Paper›PMID 38950072›Full record

ArticlePLoS neglected tropical diseases2024

A Nanobody/Monoclonal Antibody "hybrid" sandwich technology offers an improved immunoassay strategy for detection of African trypanosome infections.

Steven Odongo, Bo-Kyung Jin, Hang Thi Thu Nguyen, Magdalena Radwanska, Stefan Magez

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Steven OdongoLaboratory for Biomedical Research, Department of Molecular Biotechnology, Environment Technology and Food Technology KR01, Ghent University Global Campus, Incheon, South Korea.ORCID 0000-0002-8503-8897
Bo-Kyung JinLaboratory for Biomedical Research, Department of Molecular Biotechnology, Environment Technology and Food Technology KR01, Ghent University Global Campus, Incheon, South Korea.
Hang Thi Thu NguyenLaboratory for Biomedical Research, Department of Molecular Biotechnology, Environment Technology and Food Technology KR01, Ghent University Global Campus, Incheon, South Korea.
Magdalena RadwanskaLaboratory for Biomedical Research, Department of Molecular Biotechnology, Environment Technology and Food Technology KR01, Ghent University Global Campus, Incheon, South Korea.
Stefan MagezLaboratory for Biomedical Research, Department of Molecular Biotechnology, Environment Technology and Food Technology KR01, Ghent University Global Campus, Incheon, South Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The scarcity of reliable devices for diagnosis of Animal African trypanosomiasis (AAT) presents a limitation to control of the disease. Existing high-sensitivity technologies such as PCR are costly, laborious, time-consuming, complex, and require skilled personnel. Hence, utilisation of most diagnostics for AAT is impracticable in rural areas, where the disease occurs. A more accessible point-of-care test (POCT) capable of detecting cryptic active infection, without relying on expensive equipment, would facilitate AAT detection. In turn, early management, would reduce disease incidence and severity. Today, several ongoing research projects aim at modifying complex immunoassays into POCTs. In this context, we report the development of an antigen (Ag) detection sandwich ELISA prototype for diagnosis of T. congolense infections, which is comprised of nanobody (Nb) and monoclonal antibody (mAb) reagents. The Nb474H used here, originated from a past study. Briefly, the Nb was engineered starting from mRNA of peripheral blood lymphocytes of an alpaca immunized with soluble lysate of Trypanosoma congolense (TC13). T. congolense glycosomal fructose-1,6-bisphosphate aldolase (TcoALD) was discovered as the cognate Ag of Nb474H. In this study, splenocytes were harvested from a mouse immunized with recombinant TcoALD and fused with NS01 cells to generate a hybridoma library. Random screening of the library on TcoALD retrieved a lone binder, designated IgM8A2. Using Nb474H as Ag-capture reagent in combination with the IgM8A2 monoclonal antibody Ag-detection reagent resulted in a tool that effectively detects native TcoALD released during infection by T. congolense parasites. Hitherto, development of POCT for detection of active trypanosome infection is elusive. The Nanobody/Monoclonal Antibody (Nb/mAb) "hybrid" sandwich technology offers prospects for exploration, using the unique specificity of Nb as a key determinant in Ag capturing, while using the versatility of monoclonal Ab to adapt to various detection conditions.

Indexed as

Antibodies, MonoclonalAntibodies, ProtozoanEnzyme-Linked Immunosorbent AssayTrypanosoma congolenseTrypanosomiasis, AfricanAnimalsAntigens, ProtozoanMiceSensitivity and SpecificitySingle-Domain AntibodiesAntibodies, MonoclonalAntibodies, ProtozoanAntigens, ProtozoanSingle-Domain Antibodies

Identifiers

PMID38950072
PMCPMC11244815

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.